Business Context and Reporting Period
Company: Genmab A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2025
Filing Date: June 16, 2025
This filing serves as a report of current events pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The document incorporates by reference a company announcement regarding transactions executed under the company's share buy-back program.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions related to share repurchases rather than financial performance results.
Material Changes
Share Buy-back Program Activity:
- The company executed transactions in connection with its share buy-back program during the period of June 9-13, 2025.
- Specific details regarding the number of shares repurchased, average price, or total expenditure are contained in the referenced Exhibit 99.1 and Appendix 99.1(a) but are not explicitly detailed in the cover text of this filing.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook statements, or discussions of risks and contingencies. The document is strictly a procedural filing to disclose the occurrence of share buy-back transactions.
Investor Verification Checklist
- Review Exhibit 99.1 and Appendix 99.1(a) for the exact number of shares repurchased and the total cost incurred between June 9-13, 2025.
- Verify the remaining authorization limit for the share buy-back program following these transactions.
- Confirm the average price per share paid during this specific trading window.